Menu
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why I Own Novocure Stock (NVCR)


Brian Orelli, biotech contributor and writer at The Motley Fool, joins the channel to discuss why he owns Novocure (NASDAQ: NVCR) stock. Check out his reasoning in this video!

*Stock prices used were the midday prices of Aug. 10, 2022. The video was published on Aug. 21, 2022.

Continue reading


Source Fool.com

Like: 0
Share

Comments